BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has entered into a definitive agreement to acquire Alesta Therapeutics, a clinical-stage biotechnology company, to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions